Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy

Overview of attention for article published in Molecular Therapy, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 7 patents

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

INHIBITION OF PROSTAGLANDIN D2 RECEPTOR 1 AS MEANS FOR TREATING CANCER

Application WO-2025104233-A1

World Intellectual Property Organisation (WIPO)

22 May 2025

HEMATOPOIETIC PROSTAGLANDIN SYNTHASE (HPGDS) INHIBITION FOR TREATING CANCER

Application WO-2025104229-A1

World Intellectual Property Organisation (WIPO)

22 May 2025

INHIBITION OF PROSTAGLANDIN D2 RECEPTOR 2 AS MEANS FOR TREATING CANCER

Application WO-2025104238-A1

World Intellectual Property Organisation (WIPO)

22 May 2025

Gene therapy for treating hemophilia A

Grant US-11779656-B2

United States of America

10 Oct 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.